Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-10-18
1991-02-26
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514894, 424 9, A61K 4900, A61F 31585
Patent
active
049962000
ABSTRACT:
There is provided an oral antihepatopathic composition comprising protoporphyrin IX-Zn(II) complex. By oral administration, the complex can suppress the elevation of GPT and GOT as well as the increase of liver weight in a living body suffering from hapatic disorder, which contributes to prevention or relief of the disease.
REFERENCES:
Qato et al.-Biochem. J. (1985), 226, 51-57.
Maines et al.-Biochem. J. (1984), 217, 409-417.
Maines-Biochimica Et Biophysica Acta, 673 (1981), 339-350.
"Bilirubin Metabolism and the Hereditary Hyperbilirubinemias", Paul D. Berk, Gastroenterology, vol. 5, 4th Edition, 1985, pp. 2732-2797.
Fukuda Yozo
Nishimura Yasuhiro
Suzuki Motoko
Friedman Stanley J.
Hamair Chemicals, Ltd.
Hook Greg
LandOfFree
Use of Zn-protoporphyrin for hepatitis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Zn-protoporphyrin for hepatitis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Zn-protoporphyrin for hepatitis treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-294017